0001140361-15-014293.txt : 20150403 0001140361-15-014293.hdr.sgml : 20150403 20150403114306 ACCESSION NUMBER: 0001140361-15-014293 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150401 FILED AS OF DATE: 20150403 DATE AS OF CHANGE: 20150403 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SALIX PHARMACEUTICALS LTD CENTRAL INDEX KEY: 0001009356 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943267443 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8510 COLONNADE CENTER DRIVE CITY: RALEIGH STATE: NC ZIP: 27615 BUSINESS PHONE: (919) 862-1000 MAIL ADDRESS: STREET 1: 8510 COLONNADE CENTER DRIVE CITY: RALEIGH STATE: NC ZIP: 27615 FORMER COMPANY: FORMER CONFORMED NAME: SALIX HOLDINGS LTD DATE OF NAME CHANGE: 19970807 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CREECH TIMOTHY J CENTRAL INDEX KEY: 0001183898 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23265 FILM NUMBER: 15750566 MAIL ADDRESS: STREET 1: C/O TRIMERIS, INC. STREET 2: 3518 WESTGATE DR. SUITE 300 CITY: DURHAM STATE: NC ZIP: 27707 4 1 doc1.xml FORM 4 X0306 4 2015-04-01 1 0001009356 SALIX PHARMACEUTICALS LTD SLXP 0001183898 CREECH TIMOTHY J 8510 COLONNADE CENTER DRIVE RALEIGH NC 27615 0 1 0 0 See Remarks Common Stock 2015-04-01 4 U 0 4065 173 D 0 D Common Stock 2015-04-01 4 D 0 21372 173 D 0 D Shares tendered for an offer price of $173.00 per share in cash, subject to any applicable withholding taxes, pursuant to the tender offer consummated on April 1, 2015 pursuant to the terms of the Agreement and Plan of Merger, dated as of February 20, 2015 (as amended, the "Merger Agreement"), by and among the Issuer, Valeant Pharmaceuticals International ("VPI"), a Delaware corporation and a wholly owned subsidiary of Valeant, Sun Merger Sub, Inc. ("Merger Sub"), a Delaware corporation and a wholly owned subsidiary of VPI, and solely for purposes of guaranteeing VPI's and Merger Sub's obligations under the Merger Agreement, Valeant Pharmaceuticals International, Inc. ("Valeant"), a British Columbia corporation. Pursuant to the terms of the Merger Agreement, on April 1, 2015, each share of the Issuer's restricted stock issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) was converted into the right to receive $173.00 per share in cash, subject to any applicable withholding taxes. Senior Vice President, Finance and Administrative Services, and Acting Chief Financial Officer /s/ Timothy J. Creech 2015-04-03